Renal Ischaemia Reperfusion Injury (R-IRI) can cause Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD), resulting in significant morbidity and mortality. To understand the underlying mechanisms, reproducible small-animal models of AKI and CKD are needed. We describe here how innovative technologies for measuring kidney function non-invasively in small rodents allowed successful refinement of the R-IRI models, and enabled the transition from AKI to CKD to be monitored longitudinally in individual animals.
Introduction
Acute kidney injury (AKI) and chronic kidney disease (CKD) are leading causes of morbidity and mortality 1 . Pre-renal causes of AKI can be attributed to hypovolaemia 2 , cardiac bypass surgery 3 and clamping of the renal pedicle during partial nephrectomy 4 . These lead to renal ischaemia-reperfusion injury (R-IRI) which progresses from AKI to functional recovery in most 2 , although severe R-IRI AKI is a well-recognised cause of CKD. AKI in children significantly increases their risk of developing CKD 5, 6 and an episode of AKI in an adult with CKD accelerates their progression towards end-stage renal disease (ESRD) 7 .
Despite the need for therapeutic adjuncts to reduce the severity of AKI and progression to CKD, therapies are still lacking. A range of potential treatments have been investigated, but none are recommended due a lack of efficacy in clinical trials 8 . In view of this ongoing need, pre-clinical evaluation of novel therapies for AKI and CKD is required.
The Acute Dialysis Quality Initiative (ADQI) group stratify AKI severity using the RIFLE classification. RIFLE has GFR, creatinine and urine output criteria, although the urine output criteria are rarely used 9 . Levels of injury are classed as 'Risk' (>25% GFR decrease), 'Injury' (>50% GFR decrease), 'Failure' (>75% GFR decrease), 'Loss' (complete loss of function > 4 weeks) and 'ESRD' 10 . In AKI the patients most in need of additional therapies are those in the 'Failure' group 11 who have a 46.5% mortality rate. Developing a clinically relevant preclinical model of AKI enables therapies to be trialled appropriately 12 .
R-IRI is a pre-clinical model of AKI 13 caused by unilateral or bilateral clamping of the renal pedicles, and in the former, with or without contralateral nephrectomy. Creation of R-IRI varies widely between groups who use differing anaesthetic agents, clamping times, temperature control and approaches to the kidney [14] [15] [16] , all of which could cause alteration in the severity R-IRI induced injury. Additionally, the genetic background and strain of animal can affect the progression of AKI and CKD 17 . R-IRI is a notoriously variable model of kidney injury 16 and refinement enables fewer animals to be used when looking at therapeutic effects.
Bilateral R-IRI creates an injury that affects the global glomerular filtration rate (GFR), akin to the clinical situations described above. A global reduction in GFR is classically measured using blood markers of kidney function which do not have a linear relationship with GFR 18, 19 .
In small rodents these are typically performed at the experimental endpoint due to the volumes of blood required 20 . By contrast, non-invasive methods of measuring renal clearance enable monitoring of kidney function in the same animal 21, 22 . Transdermal measurement of FITC-Sinistrin clearance time allows global GFR to be calculated 22, 23 , making it an ideal tool for longitudinally monitoring renal function after bilateral R-IRI and reducing the numbers of animals required for a study.
Unilateral R-IRI with delayed nephrectomy enables a more severe AKI to be produced because the healthy kidney provides function whilst the severely injured kidney recovers adequate function for survival. It is a model that enables the progression to CKD to be studied as well as the most severe manifestation of AKI. When a unilateral R-IRI is performed without nephrectomy the overall GFR does not reflect the function of the injured kidney, which will be substantially less than the uninjured kidney. This makes it difficult to establish the optimal time point for removing the healthy kidney to enable transdermal GFR monitoring to be performed. Refinement of the model is important from a NC3Rs perspective because if the healthy kidney is removed before the injured kidney has regained sufficient function, the animal will experience suffering.
We have previously shown that measurements of IRDye 800 clearance using multispectral optoacoustic tomography (MSOT) correlate well with histological evidence of kidney damage in an Adriamycin model of injury 20 . Moreover, a recent study has shown that IRDye 800 can be measured repeatedly and reproducibly in the kidneys of healthy mice using MSOT, indicating that longitudinal studies could be performed with high confidence 24 .
In unilateral R-IRI, non-invasive monitoring of the injured and uninjured kidney using MSOT could enable the function of each kidney to be simultaneously and individually tracked.
In this study we used the transcutaneous device to measure GFR longitudinally in mice, in order to establish the effect of clamping time on GFR in the bilateral R-IRI model. This allowed us to determine if GFR returned to baseline levels after a 2 week recovery period. It also enabled us to explore whether the degree of GFR impairment that occurs immediately following R-IRI, can predict the degree of histological damage that occurs subsequently. By exploring the contribution of anaesthetic time to the severity of injury, we refined the model to reduce variability. Finally, we created a clinically relevant model of AKI, representing severe AKI leading to CKD, but remaining NC3Rs compliant. To this end, we explored the potential of an emerging technology, MSOT, which enables non-invasive visualisation of the kidneys, and monitoring of their function longitudinally. 
Materials and Methods

Animals
AKI Model
Briefly, after induction of anaesthesia with inhaled oxygenated isoflurane, the animal was transferred to a heat pad with a rectal temperature probe, body temperature set to 37°C.
Surgery was commenced after the temperature reached 36.5°C. A dorsal approach was taken 25 On day 14, animals were culled and blood and kidneys collected.
Refined AKI Model
A refined AKI model was performed in 6 animals. The main adjustment was standardisation of pre-clamping anaesthetic time to 30 minutes between the start of anaesthetic and commencement of surgery. For further details see Supplementary Information 1.c and Supplementary Figure 1 . GFR was measured pre-operatively and day 1 and 3 postoperatively. Blood and kidneys were collected after animals were culled on day 3.
CKD Model
To create CKD secondary to R-IRI, prolonged unilateral renal pedicle clamping was performed in 3 mice using the 'Refined AKI model' with clamping of the left renal pedicle for 40 minutes. MSOT was undertaken on days 1, 4, 7, 10, 14, 21 and 28 after injury, and nephrectomy of the uninjured kidney was performed on day 29 ( Supplementary Figure 2A ). GFR was measured on day 30, animals were culled, and blood and kidneys retrieved.
Refined CKD Model
Following the first CKD experiment, the model was refined by performing right-sided renal pedicle clamping, enabling better visualisation of the kidney with MSOT. The contralateral nephrectomy was performed on day 14 and the endpoint of the experiment was 6 weeks after R-IRI (Supplementary Figure 2B ).
Transdermal FITC-Sinistrin Clearance Measurement
FITC-Sinistrin Clearance was measured in all mice, as previously described 23 . The half-life of FITC-Sinistrin was converted to GFR using the formula 22
to enable the GFR of mice with no excretion to be included in the analysis.
Absolute GFR values and the proportional change in GFR compared to baseline measurements were analysed. The proportional change was correlated with the 'RIFLE' classification of kidney injury, depicting the levels of Risk, Injury and Failure as described by the ADQI working group 10 . The values for each level were calculated from the mean of the baseline measurements, which followed a normal distribution ( Supplementary Figure 3) .
Multi-Spectral Optoacoustic Tomography (MSOT)
The inVision 256-TF MSOT imaging system (iThera Medical, Munich, Germany) was employed in the CKD model, using IRDye 800 carboxylate (IRDye) to measure renal kinetics in the injured and healthy contralateral kidneys (details of acquisition and analysis within Supplementary Information 1.d).
Serum analysis
Animals were culled in a rising concentration of CO2. Once death was confirmed, cardiac puncture was performed to collect blood. This was clotted for 2 hours and centrifuged at 2000g for 20 minutes. Serum was collected and re-centrifuged at 75g for 4 minutes to remove all blood. Samples were stored at -20°C until analysis and repeat freeze-thawing was avoided. Creatinine (Detect X Serum Creatinine Detection Kit, Arbor Assays, Ann Arbor, MI, USA) was assessed using the modified Jaffe Reaction. Urea (QuantiChrom Urea Assay Kit, BioAssay Systems, Hayward, CA, USA) was assessed using a colorimetric reaction and Cystatin C (Quantikine ELISA, R&D Systems, UK) was analysed using an ELISA method.
Histopathology
Kidneys were collected and fixed in 4% paraformaldehyde. They were processed in paraffin and sections of 4 µm were stained with and Picrosirius Red (PSR) to assess for cortical deposition of collagen I and III. Sections were analysed by a veterinary histopathologist blinded to the intervention. Cortical collagen deposition was graded 0-4 in a single section of each kidney, based on the percentage of the cortex judged to show increased collagen deposition by the histopathologist (Supplementary Figure 6 ).
Statistical Analysis
One-way ANOVA was used to compare GFR at different time points after injury, serum and 
Results
In bilateral R-IRI, GFR is inversely correlated with subsequent collagen deposition
Bilateral R-IRI was performed using 3 different clamp times -25, 27.5 and 30 min -to establish which was best-able to induce a severe, survivable injury. Compared with the sham group, the GFR of all injured animals was significantly reduced on day 1, irrespective of clamp time, but had returned to near baseline levels by day 14. There was no significant difference between R-IRI groups, but the trend was for the GFR to be lower in animals with longer clamp times ( Figure 1A) . The proportional GFR change showed that the majority of animals entered the RIFLE 'failure' category on day 1 after injury in the 27.5 and 30 minute groups, but had mostly recovered by day 14 (Figure 1B ).
There was weight loss in all groups with the nadir occurring 4 days after R-IRI (Supplementary Figure 4A ). The mortality rate was higher in the 30 min group (33% compared with 17% in the 27.5 and 25 min groups; Supplementary Figure 4B Longer clamping was associated with increased collagen deposition on day 14 ( Figure 3A) , which showed a strong correlation with the day 1 GFR ( Figure 3B ). This indicates that following R-IRI, the risk of developing renal fibrosis is related to the degree of initial GFR impairment, reflecting the severity of the initial injury. A surprising finding, however, was that the GFR was not substantially affected by longer clamp times, raising the question of whether other extrinsic factors, such as anaesthetic time, could be affecting the severity of injury.
Pre-clamping anaesthetic time correlates with the degree of GFR impairment
The model of bilateral R-IRI is notoriously variable 15 , even when clamp times and temperature are standardised. To assess the impact of external experimental variables on GFR, univariate linear regression analysis was performed. This revealed that, independent of clamping time, the total anaesthetic time had an impact on the day 1 GFR. The GFR was particularly affected by the time between anaesthetic commencement and placement of first clamp ( Figure 4A ). There was no significant relationship between clamping time or postclamping time and GFR ( Figure 4B ), nor surgical order, which heat pad was used, or the animal's weight ( Figure 4C ).
We refined the bilateral R-IRI model (27.5 min clamp time) by standardising the pre-surgical anaesthetic time to 30 minutes from the start of anaesthetic to start of surgery, whilst continuing to monitor total anaesthetic duration. We compared this standardised anaesthetic (SA) group to the previously described non-standardised anaesthetic (NSA) group and found that the SA group had a reduction in day 1 GFR ( Figure 5 ), suggesting that a more severe but more reproducible injury level was achieved. Standardising pre-surgical time meant that surgery was more regimented, resulting in a significantly shorter overall anaesthetic time, but a longer, less variable pre-clamping time. This highlights that it is preclamping anaesthetic time, rather than total anaesthetic duration, that has the greatest impact on the GFR.
Assessing individual renal function in a mouse model of R-IRI-induced CKD using MSOT
A limitation of the bilateral R-IRI model is that it does not model the severest AKI which consistently lead to CKD. Whilst patients with severe AKI can be kept alive with dialysis until renal recovery, mice cannot and very severe AKI is fatal. This can be overcome by prolonged clamping of one kidney to induce a very severe injury, and then removing the healthy kidney after the injured kidney has recovered. If the injured kidney has not recovered sufficiently before contralateral nephrectomy there is potential for animal suffering. To address this, we used MSOT to establish the time required for sufficient recovery of function. We first performed a pilot experiment with 40 min unilateral clamping, and monitored single kidney function in both the healthy and injured kidney with MSOT over 4 weeks by longitudinally assessing the pharmacokinetics (PK) of IRDye in the renal cortex ( Supplementary Figure 2) .
We established the most appropriate model for monitoring IRDye PK by testing the fit of biexponential and triexponential models to MSOT curves. Triexponential modelling fitted better than other models, both visually (Supplementary Figure 5 ) and using the Akaike Information Criterion 26 . The tmax (time between administration of IRDye and maximum peak of the curve) distinguished between injured and uninjured kidneys consistently and was therefore further tested using linear mixed effects models. Using the uninjured kidney as a fixed effect there were significant differences between injured and uninjured kidney (p=0.044) on day 1 ( Figure 6A ). The injured kidney's function improved to levels equivalent to the uninjured kidney in week 2 (p=0.75) but then declined significantly over the subsequent 2 weeks ( Figure 6B ).
GFR measurements performed after nephrectomy on day 29 revealed significant reduction in GFR to an average of 20% of baseline function ( Figure 7A) , showing progression from AKI to CKD. Serum markers of function reflected significant injury above published normal ranges (Supplementary Table 2 ) 27, 28 . All injured kidneys weighed less than the uninjured kidneys, and there was collagen deposition within all injured kidneys ( Figure 7B,C) . The impaired GFR at the study end-point, accompanied with increased levels of serum biomarkers and histological damage, indicated that 40 min clamping with subsequent nephrectomy produces a severe renal injury resulting in CKD.
Refinement of a unilateral model of R-IRI-induced CKD results in a survivable, reproducible and persistent renal injury.
In the pilot study of unilateral R-IRI and subsequent contralateral nephrectomy, MSOT showed a nadir of injury between days 10 and 14 ( Figure 6A ). Performing contralateral nephrectomy when the injured kidney is functioning optimally reduces animal suffering and improves survival. It also enables transdermal FITC-Sinistrin clearance to be measured, which is quicker to perform than MSOT and has the advantage that it can be undertaken in awake animals 20, 29 . The CKD model was refined by performing contralateral nephrectomy on day 14 after R-IRI ( Supplementary Figure 2B ).
In the refined study, the tmax differentiated between the injured and uninjured kidney on day 1 after R-IRI and significant reduction in tmax was seen between day 1 and day 9 after R-IRI ( Figure 8A) . One animal developed diarrhoea on day 12 and was excluded from further experimentation. Following contralateral nephrectomy all animals had significant, persistent reduction in GFR ( Figure 8B) , without any significant changes in weight ( Figure 8C ). All animals had elevated serum markers of kidney injury ( Supplementary Table 1 ) and consistent collagen deposition ( Figure 8D ). This demonstrates that MSOT is suitable to monitor kidney function after R-IRI based on the tmax of IRDye clearance.
Overall, we show that performing a contralateral nephrectomy on day 14 after R-IRI caused consistent, survivable CKD which can be monitored longitudinally with transdermal FITC-Sinistrin clearance.
Discussion
Here we report, for the first time, how non-invasive monitoring of renal function can be used to identify factors which add variability to the R-IRI model, leading to its refinement. R-IRI represents a variety of clinical situations 13 and its applicability to clinical practice is becoming increasingly evident with the recognition that one episode of ischaemic AKI can lead to nephron loss, tubule-interstitial atrophy and fibrosis.
The majority of clinical causes of R-IRI AKI affect both kidneys and therefore a bilateral R-IRI model was selected for AKI studies. Clinical literature describes that a severe episode of AKI is associated with an increased risk of developing CKD 30 and the finding of collagen deposition 14 days after R-IRI AKI supports this. Concluding AKI studies on day 3 prevented the most severe weight loss in animals whilst still enabling the study of acute derangement of renal function. However, extending the study period enables the transition of AKI to CKD to be further examined. When considering CKD it was apparent that a survivable but severe, consistent model of kidney injury was required. Prolonged unilateral clamping with delayed nephrectomy caused less suffering to the animal but a consistent, reproducible reduction in GFR with more collagen deposition and less variability. When selecting whether unilateral or bilateral R-IRI be undertaken, the suffering of animals needs to be taken into account. The loss of animals can have an effect on experimental results and this should be considered when planning the experiments.
Description of the GFR as both an absolute measure and as a proportional measure of the baseline GFR enables the RIFLE classification 10 to be applied to assess loss of renal function.
This approach to describing the GFR is novel and enables results to be reported using clinically relevant descriptors. Therefore, applying RIFLE enables appropriate power calculations to be performed for therapeutic studies.
Standardisation of pre-clamping anaesthetic time achieves a more reproducible R-IRI model
Refinement of the R-IRI model of AKI was possible because the duration of anaesthetic prior to clamping has a significant impact on day 1 GFR. We postulate that the duration of isoflurane anaesthetic is important due to the hypotensive effects which have previously been reported 31 . Standardising this variable enables appropriate prioritisation of tasks during R-IRI surgery (placement of clamps at the correct time should be prioritised over closure) to achieve a more reproducible model. Standardisation causes a reduction in both GFR and variability, giving the potential to reduce the number of animals required to show therapeutic efficacy.
MSOT can be used to determine the function of an injured kidney after R-IRI
Previous publications have described measuring the delay between tmax in the renal cortex and pelvis 20 using MSOT, and the area under the curve (AUC) after drug induced global renal injury 32 . Neither of these could be applied to the R-IRI model due to the difficulty of imaging both renal pelvises in one plane. This problem is compounded following surgery due to postoperative oedema and over-lying sutures. However, it was possible to accurately identify and image both renal cortices simultaneously after R-IRI, and obtain consistent tmax measurements.
Whilst it is not appropriate to use IRDye clearance to calculate GFR, due to its high levels of protein binding 20, 33 , it can be used as a surrogate measure of renal function due to its sole excretion through the glomeruli. After assessment of IRDye PK, we found that tmax best distinguishes the injured from the uninjured kidney. Additionally, we determined that the injured kidney, similarly to the trajectory in the acute model, recovered by day 10 followed by prolongation of tmax, indicating the progression from AKI to CKD.
Contralateral nephrectomy on day 14 after prolonged unilateral R-IRI produced a survivable, reproducible CKD model
Refining the CKD model by performing contralateral nephrectomy on day 14 resulted in non-significant weight loss, showing good health of the animals. While reduction in GFR persisted after contralateral nephrectomy, a slight non-significant upward trend was seen which probably represented the adaptation that has been described due to glomerular hyperfiltration 34 . However, the GFR reduction in week 6 remained significant compared to baseline levels. Development of this model demonstrates the utility of long-term accurate GFR monitoring, particularly when assessing the impact of therapeutic agents in an animal with predictable CKD.
In conclusion, the application of in-vivo non-invasive measures of renal function have enabled the refinement of models of both AKI and CKD after R-IRI. Transdermal GFR measurements correlate well with histological markers of kidney disease and enable the refinement and reduction of animals required for future studies of therapies in these models. MSOT is feasible in animals following R-IRI surgery and modelling of the clearance of IRDye using a tri-exponential curve and tmax enables reproducible monitoring of the function of the injured and uninjured kidney.
Application of the RIFLE criteria for GFR to pre-clinical studies enables the translation of results to the clinic, ensuring that therapeutic studies show clinically important differences. 
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